Latest filing published 28 Mar 2014 for NUTRA PHARMA CORP.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -81.0%Entry US$3.90 · Close at T+365 US$0.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stewart Alan Lonky: trading record in brief
Stewart Alan Lonky discloses dealings in Nutra Pharma Corp to SEC (Form 4). Over a trading history stretching from 18 March 2008 to 18 October 2013, the count stands at 7 filings.
Purchases make up the whole of the open-market record (2 purchases, €1,576). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants.
The newest entry dates from 28 March 2014: a share grant, in Nutra Pharma Corp. The last purchase on record was published on 30 March 2011, which is 5,702 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stewart Alan Lonky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,730,000 sharesNPHC Common StockSEC:0001144204-14-018923:0
- 70,000 shares@ US$0.008NPHC Common StockSEC:0001144204-14-018923:1
- 5,000,000 sharesNPHC Common StockSEC:0001144204-13-018044:0
- 4,400,000 sharesCommon StockSEC:0001144204-12-022609:0
- 10,000 shares@ US$0.08NPHC Common StockSEC:0001144204-11-018090:0Canonical exit: 21 Mar 2011 (T+90)
- 10,000 shares@ US$0.13NPHC Common StockSEC:0001144204-11-018090:1Canonical exit: 20 Apr 2011 (T+90)
- 2,500,000 shares0Common StockSEC:0001144204-10-001777:0
7 of 7 declarations